Cipher Pharmaceuticals

230 articles with Cipher Pharmaceuticals

• Cipher Pharma Proposes Adding Robert Tessarolo And Arthur Deboeck To Board Of Directors

  4/12/2017

• Cipher Pharma Announces Amendment To Debt Agreement And Partial Prepayment

  4/3/2017

• Former Celgene Exec to Helm Cipher Pharma

  3/22/2017

• Cipher Pharma Reports 2016 Q4 & Year-End Financial Results

  3/2/2017

• Notice Of Cipher Pharma Q4 And Year-End 2016 Conference Call

  2/17/2017

• Cipher Pharma Announces Plans To Voluntarily Delist From NASDAQ

  11/29/2016

• Cipher Pharma Reports Q3 2016 Financial Results

  11/11/2016

• Cipher Pharma Announces Management Change

  11/11/2016

• Cipher Pharma Responds To Request For Comment From IIROC

  10/31/2016

• Notice Of Cipher Pharma Q3 2016 Conference Call

  10/27/2016

• Cipher Pharma Brings Aboard Former Nuvo Pharma Exec as New CFO

  9/2/2016

• Cipher Pharma Reports Q2 2016 Results Highlighted By 32% Revenue Growth And $3.1 Million Cash From Operations

  8/10/2016

• Cipher Pharma Shakes Up Board as Four Members Step Down, Effective Immediately

  8/9/2016

• Cipher Pharma Announces Preliminary Q2 2016 Results Highlighted By 30+% Revenue Growth And $3.0+Million Cash From Operations

  8/3/2016

• Notice Of Cipher Pharma Q2 2016 Conference Call

  7/20/2016

• Cipher Pharma Announces Ozenoxacin Accepted For Review By Health Canada

  7/12/2016

• Special Committee Of Cipher Pharma Responds To Early Warning Report Filed By 1207407 Ontario Limited

  7/6/2016

• Special Committee Of Cipher Pharma Responds To Early Warning Report Filed By 1207407 Ontario Limited

  7/6/2016

• Cipher Pharma Out-Licenses Rights To ASF-1096 For Anorectal Disorders

  6/20/2016

• Cipher Pharma To Present At Two Upcoming U.S. Investor Conferences

  5/31/2016